Form4insider filings, from the source

SEC Form 4 · accession 0000911916-16-000691

CoLucid Pharmaceuticals, Inc. · CLCD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas P. Mathers
Officer — Chief Executive Officer · Director
Period of report
Nov 5, 2016
Accepted (ET)
Nov 7, 2016 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 5, 2016M3,755—A250,422D
Common StockF2,F3Nov 7, 2016S1,502$28.5732D248,920D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F4—Nov 5, 2016M3,755D——Common Stock3,755112,658D

Explanation of responses